Regarding US FDA guidelines [Bioanalytics]

posted by sri – 2009-07-09 15:01 (6199 d 16:15 ago) – Posting: # 3945
Views: 8,418

Dear all,
Please clarify me the below sentense which is present in 'Guidance for Industry Bioanalytical Method Validation'.

The calibration (standard) curve should cover the expected unknown sample concentration range in addition to a calibrator sample at lower limit of quantification.


Regards,
Sri

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
296 visitors (0 registered, 296 guests [including 29 identified bots]).
Forum time: 07:17 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5